Tumor Analysis
Quantitative single nucleotide polymorphism analysis proves powerful tool
Published in Cancer Weekly, April 1st, 2003
"Single nucleotide polymorphisms are the most abundant genetic markers in the human genome whose analyses can be easily conducted on a large scale. Most established methods for high-throughput single nucleotide polymorphism analyses are qualitative and are not suitable for genetic analysis of archived tumor specimens, which have compromised tissue integrity and normal tissue contaminations," researchers in the United States report.
"Recent studies have focused on the development of quantitative methods for single nucleotide polymorphism analyses that can tolerate such...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-04-01)
More Articles from Cancer Weekly
- Breast Cancer Diagnosis
NIST, UW-Madison research may lead to new breast cancer detection methods - Cancer Metastasis
Thrombin generation correlates with biomarkers in advanced prostate cancer - Bone Cancer
Pulmonary metastasis can arise after surgery for osteosarcoma - Cancer Markers
Disruption of the HIC1 gene may predispose mice to gender-specific malignancy - Colon Cancer Screening
Potential blood test could predict risk - Rhabdomyosarcoma
Gene that drives apoptosis also plays key role in development of skeletal muscle - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
